news
News
home > industry news > international express: a new engine to promote high-quality development of the pharmaceutical industry
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
in recent years, with the rapid development of global trade, the international express delivery industry is expanding its scale with its efficient and convenient services, providing convenience and support for the pharmaceutical industry. especially for pharmaceutical companies, international express delivery services are not only a means of transporting goods, but also a bridge for cross-border cooperation.
eddingpharm: a leader in innovation-driven high-quality development
as a leading innovative drug r&d company in china, eddingpharm plays an important role in international express delivery services. in recent years, eddingpharm has continued to increase its r&d investment and built a full life cycle r&d system covering new drug discovery, preclinical research, clinical trials and post-marketing. through in-depth cooperation with top international scientific research institutions and companies, eddingpharm continues to introduce and absorb the world's advanced r&d technology and management experience, promoting the continuous upgrading of its own technology platform and the rapid expansion of its r&d pipeline.
international express service: helping the pharmaceutical industry to develop with high quality
international express services play an important role in the pharmaceutical industry, mainly in the following aspects:
future outlook
with the continuous emergence of innovative r&d results and the in-depth promotion of internationalization strategy, eddingpharm is accelerating towards a new stage of high-quality development. eddingpharm will continue to uphold the concept of "patient-centered, innovation-driven development", continuously increase r&d investment, expand r&d fields, and strive to provide more safe, effective and affordable innovative drugs for chinese and global patients.